ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,476 | -28.1% | 2,715,599 | +1.2% | 0.01% | -27.3% |
| Q2 2023 | $75,726 | +100.1% | 2,684,352 | +22.0% | 0.01% | +83.3% |
| Q1 2023 | $37,844 | -13.7% | 2,200,169 | +1.1% | 0.01% | -14.3% |
| Q4 2022 | $43,839 | -99.9% | 2,176,700 | -1.9% | 0.01% | -12.5% |
| Q3 2022 | $48,037,000 | -60.2% | 2,217,740 | -48.4% | 0.01% | -46.7% |
| Q2 2022 | $120,789,000 | -37.6% | 4,298,551 | +2.4% | 0.02% | -25.0% |
| Q1 2022 | $193,704,000 | -47.4% | 4,198,180 | -4.2% | 0.02% | -39.4% |
| Q4 2021 | $368,425,000 | +48.2% | 4,382,881 | +17.5% | 0.03% | +43.5% |
| Q3 2021 | $248,596,000 | +43.4% | 3,730,425 | +14.4% | 0.02% | +43.8% |
| Q2 2021 | $173,409,000 | +268.6% | 3,259,568 | +200.6% | 0.02% | +220.0% |
| Q1 2021 | $47,045,000 | -17.2% | 1,084,246 | -0.9% | 0.01% | -16.7% |
| Q4 2020 | $56,824,000 | +57.2% | 1,094,026 | -1.1% | 0.01% | +50.0% |
| Q3 2020 | $36,156,000 | -36.6% | 1,106,020 | -6.9% | 0.00% | -42.9% |
| Q2 2020 | $57,027,000 | – | 1,187,566 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |